Lung mycobacteriosis - Clinical presentation, diagnostics and treatment;Mikobakteriozy płuc - Obraz kliniczny, diagnostyka i leczenie

Pneumonologia i Alergologia Polska

Volumn 78, Issue 2, 2010, Pages 138-147

  Wilińska, Ewelina ^a   Szturmowicz, Monika ^a  

^a Klinika Chorób Wewn trznych Klatki Piersiowej   (Poland)

Author keywords

Antituberculous drugs; Mycobacteriosis; Mycobacterium avium complex; Mycobacterium kansasii; Nontuberculous mycobacteria

Indexed keywords

ANTIINFECTIVE AGENT;

CLASSIFICATION; HUMAN; ISOLATION AND PURIFICATION; LUNG DISEASE; MICROBIOLOGY; MYCOBACTERIOSIS; MYCOBACTERIUM; RESPIRATORY TRACT INFECTION; REVIEW;

ANTI-INFECTIVE AGENTS; HUMANS; LUNG DISEASES; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 77951882375     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Griffith D.E., Aksamit T., Brown-Elliott B.A. i wsp. An official ATS/IDSA statement: diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am. J. Resp. Crit. Care Med. 2007; 175: 367-416.
2. Field S.K., Cowie R.L. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006; 129: 1653-1672.
3. Słupek A. Mikobakteriozy. W: Rowińska-Zakrzewska E. (red.). Gruźlica w praktyce lekarskiej. Wydawnictwo Lekarskie PZWL, Warszawa 2000; 271-290.
4. Daley C.L., Heifets L. Other mycobacteria causing human disease. W: Schaaf H.S., Zumla A. (red.). Tuberculosis. Saunders, Philadelphia 2009: 60-74.
5. Yeager H., Farah K.E. Nontuberculous mycobacterial syndromes. W: Schlossberg D. (red.). Tuberculosis and nontuberculosis mycobacterial infections. McGraw-Hill, New York 2006; 413-418.
6. Arend S.M., van Soolingen D., Ottenhoff T. Diagnosis and treatment of lung infection with nontuberculous mycobacteria. Curr. Opin. Pulm. Med. 2009; 15: 201-208.
7. Runyon E.H. Anonymous mycobacteria in pulmonary disease. Med. Clin. North Am. 1959; 43: 273-290.
8. Wolinsky E. Nontuberculous mycobacteria and associated disease. Am. Rev. Respir. Dis. 1979; 119: 107-159.
9. von Reyn C.F., Horsburgh C.R., Olivier K.N. i wsp. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int. J. Tuberc. Lung Dis. 2001; 5: 1122-1128.
10. Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest 2008; 133: 243-251.
11. Janowiec M., Mleczko H., Krychniak W. i wsp. Wyste{ogonek}powanie mykobakterii atypowych w dobranych ośrodkach badawczych w latach 1971-1974. Analiza danych środowiskowych i klinicznych. Pneumonol. Pol. 1977; 45: 353-361.
12. Żbikowski H. Wyste{ogonek}powanie pra{ogonek}tków atypowych u chorych z gruźlica{ogonek} płuc na wybranych terenach w kraju, w latach 1970--1974. Pneum. Pol. 1980; 48: 357-366.
13. Marras T.K., Chedore P., Ying A. M, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007; 62: 661-661.
14. Henry M.T., Inamdar L., O'Riordain D., Schweiger M., Watson J.P. Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur. Respir. J. 2004; 23: 741-746.
15. Bodle E.E., Cunningham J.A., Della-Latta P., Schluger N.W., Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg. Infect. Dis. 2008; 14: 390-396.
16. Khan K., Wang J., Marras T.K. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am. J. Respir. Crit. Care Med. 2007; 176: 303-313.
17. Maimon N., Brunton J., Chan A.K., Marras T.K. Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept. Thorax 2007; 62: 739-740.
18. Winthrop K.L., Yamashita S., Beekmann S.E., Polgreen P.M. Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clin. Infect. Dis. 2008; 46: 1738-1740.
19. Dailloux M., Abalain M.L., Laurain C. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur. Respir. J. 2006; 28: 1211-1215.
20. Słupek A., Zwolska Z., Miller M., Rowińska-Zakrzewska E. Mykobakterioza płuc-problem diagnostyczny i wyste{ogonek}powanie w Polsce (badanie retrospektywne). Pneumonol. Alergol. Pol. 1997; 65: 326-332.
21. Sexton P., Harrison A.C. Susceptibility to nontuberculous mycobacterial lung disease. Eur. Respir. J. 2008; 31: 1322-1333.
22. Iseman M.D., Buschman D.L., Ackerson L.M. Pectus excavatum and scoliosis: thoracic anomalies associated with pulmonary disease by Mycobacterium avium complex. Am. Rev. Respir. Dis. 1991; 144: 914-918.
23. Kim R.D., Greenberg D.E., Ehrmantraut M. E i wsp. Pulmonary nontuberculous mycobacterial disease. Am. J. Respir. Crit. Care Med. 2008; 178: 1066-1074.
24. Koh W.-J., Lee J.H., Kwon Y.S. i wsp. Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest 2007; 131: 1825-1830.
25. De Groote M.A., Huitt G. Infections due to rapidly growing mycobacteria. Clin. Infect. Dis. 2006; 42: 1756-176324.
26. Yonemori K., Tateishi U., Tsuta K. i wsp. Soliter pulmonary granuloma coused by Mycobacterium avium-intracellulare complex. Int. J. Tuberc. Lung Dis. 2007; 11: 215-221.
27. Reich J.M., Johnson R.E. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The lady Windermere syndrom. Chest 1992; 101: 1605-1609.
28. Butler W.R. i wsp. Standarized method for HPLC identification of mycobacteria. UD Department of Health and Human Services 1996. http://www.cdc.gov/ncidod/dastlr/TB/hplc.pdf
29. Kopacz R., Augustynowicz-Kopeć E., Zabost A., Anielak M., Zwolska E. Molekularna identyfikacja szczepów M. avium, izolowanych od chorych, przy użyciu analizy restrykcyjnej sekwencji hsp65. Materiały naukowe IX konferencji "Biologia molekularna w diagnostyce chorób zakaźnych i biotechnologii" 2 grudnia 2006, SGGW, Warszawa.
30. Lebrun L., Espinasse F., Poveda J.D. i wsp. Evaluation of non--radioactive DNA probes for identification of mycobacteria. J. Clin. Microbiol. 1992; 30: 2476-2478.
31. Safranek T.J., Jarvis W.T., Carson L.A. i wsp. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N. Engl. J. Med. 1997; 317: 197-201.
32. Olivier K.N., Weber D.J., Wallace R.J. i wsp. Nontuberculous mycobacteria in cystic fibrosis study group. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2003; 167: 828-834.
33. Pierre-Audigier C., Ferroni A., Sermet-Gaudelas i wsp. Age--related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J. Clin. Microbiol. 2005; 43: 3467-3470.
34. Jones D., Havlir D.V. Nontuberculous mycobacteria in the HIV infected patient. Clin. Chest Med. 2002; 23: 665-674.
35. Hocqueloux L., Lesprit P., Herrmann J.L. i wsp.: Pulmonary Mycobacterium avium complex disease without dissemination in HIV-infected patients. Chest 1998; 113: 542--548.
36. Cattamanchi A., Payam N., Marras T.K. i wsp. Detailed analysis of the radiografic presentation of Mycobacterium kansasi lung disease in patients with HIV infection. Chest 2008; 133: 875--880.
37. Bloch K.C., Zwerling L., Pletcher M.J. i wsp. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann. Intern. Med. 1998; 129: 698-704.
38. Jaffery S.H., Carrillo M., Betensley A.D., Fatal pulmonary nontuberculous mycobacterial infection in a patient receiving etanercept for rheumatoid arthritis. Chest 2004; 126: 944S-945S.
39. Glazer C., Martyny J., Rose C. Hot tub asociated granulomatous lung disease from mycobacterial bioaerosols. Clin. Pulm. Med. 2008; 15: 138-144.
40. Hartman T.E., Jensen E., Tazelaar V.H., Ryu J.H. CT findings of granulomatous pneumonitis secondary to mycobacterium avium--intracellulare inhalation: "Hot tub lung". AJR 2007; 188: 1050-1053.
41. Kobashi Y., Yoshida K., Miyashita N., Niki Y., Oka M. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. J. Infect. Chemother. 2006; 12: 195-202.
42. Dautzenberg B., Piperno D., Diot P., Truffot-Pernot C., Chavin J.P.; Clarithromycin Study Group of France. Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Chest 1995; 107: 1035-1040.
43. Griffith D.E., Brown B.A., Girard W.M., Griffith B.E., Couch L.A., Wallace R.J. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. Clin. Infect. Dis. 2001; 32: 1547-1553.
44. Johnson M.M., Waller E.A., Leventhal J.P. Nontuberculous mycobacterial pulmonary disease. Curr. Opin. Pulm. Med. 2008; 14: 203-210.
45. Davis K.K., Kao P.N., Jacobs S.S. i wsp. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC Pulm. Med. 2007; 7: 1-6.
46. Mitchell J.D., Bishop A., Cafaro A., Weyant M.J., Pomerantz M. Anatomic lung resection for nontuberculous mycobacterial disease. Ann. Thorac. Surg. 2008; 85: 1887-1893.